behold.ai

Behold.ai, officially known as Behold.ai Global Technologies Limited, is a British healthtech company based in London.

Founded in 2015, it specializes in artificial intelligence-driven medical diagnostic tools for radiology, focusing on the detection of lung cancer and stroke through chest X-rays and CT scans. The company’s flagship product, the red dot® platform, analyzes radiology images to identify abnormalities quickly, providing preliminary predictive diagnoses in under 30 seconds. Behold.ai is recognized for its innovative contributions to healthcare, having won the Prix Galien UK 2022 and Prix Galien International 2024 for its red dot® solution. It is the only AI company registered with the Care Quality Commission in the UK, ensuring compliance with safety regulations. The platform has received FDA clearance and CE marking for clinical use, and it integrates seamlessly with existing hospital systems. Behold.ai primarily serves hospital systems and healthcare providers, including the UK National Health Service, aiming to enhance diagnostic accuracy and efficiency while reducing costs and workload in radiology departments.